Company profile
Modus Research and Innovation Limited
MODUS Research & Innovation - MODUS Research and Innovation
Modus Research and Innovation Limited is a UK company with status active founded in 2017 based in Scotland.
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzMjE3Njg3MWFkaXF6a2N4
Published 14 Aug 2024 16:37
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Revolutionary Accuracy in waVeguide- and photoacoustic-ENabled atmospheric sensors (RAVEN)
1 Jun 2024 to 31 May 2028
Anthropogenic greenhouse gas (GHG) emissions and deteriorating air quality are driving climate change and severely impacting human and ecosystem health, respectively. To combat these issues, new and more stringent green regulations are being implemented globally, which existing air monitoring systems are not well equipped to handle. Currently available co...
SUB-WAVELENGTH HOLOGRAPHIC LITHOGRAPHY STEPPER FOR INTEGRATED CIRCUIT PRODUCTION (HoliSTEP)
1 Jan 2024 to 31 Dec 2027
To achieve ever shrinking dimensions and higher resolutions of circuit elements, projection lithography (PL), is growing in complexity and cost to manufacturers. It is limited to producing 2D images on flat surfaces. Extension to 3D imaging is restricted by trade-off between focus depth and resolution. Advanced, cost-efficient solutions to fabricate wafer...
Next Generation Glioma Treatments using Direct Light Therapy (GlioLighT)
1 Jan 2024 to 31 Dec 2026
Glioma is an extremely lethal cancer, due largely to the inaccessible nature of the brain and diffusion of cells from the tumour site. These diffuse cells are usually too deeply embedded in the brain to safely remove by current means. Targeted Reactive Oxygen Species (ROS) generation is a promising form of glioma treatment to selectively eliminate glioma,...
NEXGEN-PD
1 Apr 2023 to 31 Mar 2027
no public description
V4F
1 Jan 2023 to 31 Dec 2026
no public description
FABrication of 3D metasurfaces to enable the next generation of high efficiency optical products
1 Dec 2022 to 30 Nov 2026
no public description
Innovative environmental multisensing for waterbody quality monitoring and remediation assessment
1 Dec 2022 to 30 Nov 2026
no public description